Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.93
-0.29 (-1.28%)
Mar 6, 2026, 10:53 AM EST - Market open
Arcus Biosciences Employees
Arcus Biosciences had 601 employees as of December 31, 2025. The number of employees decreased by 26 or -4.15% compared to the previous year.
Employees
601
Change (1Y)
-26
Growth (1Y)
-4.15%
Revenue / Employee
$410,982
Profits / Employee
-$587,354
Market Cap
2.75B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Apellis Pharmaceuticals | 739 |
| Beam Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 224 |
| Catalyst Pharmaceuticals | 182 |
| Liquidia | 170 |
| Edgewise Therapeutics | 146 |
RCUS News
- 3 days ago - Arcus Biosciences: Q4 Beat And Casdatifan's Story So Far - Seeking Alpha
- 7 days ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 8 days ago - Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update - Business Wire
- 10 days ago - Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer - Business Wire
- 22 days ago - Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates - Business Wire
- 5 weeks ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 7 weeks ago - Arcus Biosciences, Inc. (RCUS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha